Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FILT Lungen- und Thoraxdiagnostik GmbH is a specialized German medical technology company focused on non-invasive diagnostics for respiratory and pulmonary diseases. The company is a leader in the development and manufacturing of devices for the collection and analysis of exhaled breath condensate (EBC), a technique that allows for the molecular profiling of the lower respiratory tract without invasive procedures. Its flagship products, including the EcoScreen 2, ECoCheck, and EBC Analyser, enable clinicians and researchers to monitor biomarkers of airway inflammation, oxidative stress, and metabolic activity. These tools are primarily utilized in the management of asthma and COPD, as well as in the early detection of lung cancer biomarkers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FILT Lungen- und Thoraxdiagnostik.